Antiapoptotic potency of Bcl-2 proteins primarily relies on their stability, not binding selectivity
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antiapoptotic potency of Bcl-2 proteins primarily relies on their stability, not binding selectivity
Authors
Keywords
-
Journal
BLOOD
Volume 123, Issue 18, Pages 2806-2815
Publisher
American Society of Hematology
Online
2014-03-13
DOI
10.1182/blood-2013-08-519470
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Methylation profiling of normal individuals reveals mosaic promoter methylation of cancer-associated genes.
- (2015) Lasse S. Kristensen et al. Oncotarget
- Polyubiquitination and proteasomal turnover controls the anti-apoptotic activity of Bcl-B
- (2013) B van de Kooij et al. ONCOGENE
- Enhanced stability of Mcl1, a prosurvival Bcl2 relative, blunts stress-induced apoptosis, causes male sterility, and promotes tumorigenesis
- (2013) T. Okamoto et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bcl-2, Bcl-xL, and Bcl-w are not equivalent targets of ABT-737 and navitoclax (ABT-263) in lymphoid and leukemic cells
- (2012) D. Merino et al. BLOOD
- Chemical Genomics Identifies Small-Molecule MCL1 Repressors and BCL-xL as a Predictor of MCL1 Dependency
- (2012) Guo Wei et al. CANCER CELL
- Selectively targeting Mcl-1 for the treatment of acute myelogenous leukemia and solid tumors
- (2012) G. J. Gores et al. GENES & DEVELOPMENT
- Nrf2 Protein Up-regulates Antiapoptotic Protein Bcl-2 and Prevents Cellular Apoptosis
- (2012) Suryakant K. Niture et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Differences in the Mechanisms of Proapoptotic BH3 Proteins Binding to Bcl-XL and Bcl-2 Quantified in Live MCF-7 Cells
- (2012) Alexander Aranovich et al. MOLECULAR CELL
- A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer
- (2012) King Pan Ng et al. NATURE MEDICINE
- Ubiquitination, localization, and stability of an anti-apoptotic BCL2-like protein, BCL2L10/BCLb, are regulated by Ubiquilin1
- (2012) L. J. Beverly et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bcl-2 is a better ABT-737 target than Bcl-xL or Bcl-w and only Noxa overcomes resistance mediated by Mcl-1, Bfl-1, or Bcl-B
- (2012) R W Rooswinkel et al. Cell Death & Disease
- An antiapoptotic BCL-2 family expression index predicts the response of chronic lymphocytic leukemia to ABT-737
- (2011) S. Al-harbi et al. BLOOD
- Bcr-Abl ubiquitination and Usp9x inhibition block kinase signaling and promote CML cell apoptosis
- (2011) H. Sun et al. BLOOD
- Inhibitor of Nrf2 (INrf2 or Keap1) Protein Degrades Bcl-xL via Phosphoglycerate Mutase 5 and Controls Cellular Apoptosis
- (2011) Suryakant K. Niture et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mutation to Bax beyond the BH3 Domain Disrupts Interactions with Pro-survival Proteins and Promotes Apoptosis
- (2011) Peter E. Czabotar et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Noxa/Bcl-2 Protein Interactions Contribute to Bortezomib Resistance in Human Lymphoid Cells
- (2011) Alyson J. Smith et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Unified Model of Mammalian BCL-2 Protein Family Interactions at the Mitochondria
- (2011) Fabien Llambi et al. MOLECULAR CELL
- SCFFBW7 regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction
- (2011) Hiroyuki Inuzuka et al. NATURE
- Maximal killing of lymphoma cells by DNA damage-inducing therapy requires not only the p53 targets Puma and Noxa, but also Bim
- (2010) L. Happo et al. BLOOD
- Defective ubiquitin-mediated degradation of antiapoptotic Bfl-1 predisposes to lymphoma
- (2010) G. Fan et al. BLOOD
- Evidence that inhibition of BAX activation by BCL-2 involves its tight and preferential interaction with the BH3 domain of BAX
- (2010) Bonsu Ku et al. CELL RESEARCH
- The BCL-2 Family Reunion
- (2010) Jerry E. Chipuk et al. MOLECULAR CELL
- A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy
- (2010) W J Placzek et al. Cell Death & Disease
- Context-dependent Bcl-2/Bak Interactions Regulate Lymphoid Cell Apoptosis
- (2009) Haiming Dai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Membrane promotes tBID interaction with BCLXL
- (2009) Ana J García-Sáez et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- MYC-induced myeloid leukemogenesis is accelerated by all six members of the antiapoptotic BCL family
- (2009) L J Beverly et al. ONCOGENE
- Membrane Binding by tBid Initiates an Ordered Series of Events Culminating in Membrane Permeabilization by Bax
- (2008) Jonathan F. Lovell et al. CELL
- In several cell types tumour suppressor p53 induces apoptosis largely via Puma but Noxa can contribute
- (2008) E M Michalak et al. CELL DEATH AND DIFFERENTIATION
- Bcl-B Expression in Human Epithelial and Nonepithelial Malignancies
- (2008) M. Krajewska et al. CLINICAL CANCER RESEARCH
- Differential Regulation of Bax and Bak by Anti-apoptotic Bcl-2 Family Proteins Bcl-B and Mcl-1
- (2008) Dayong Zhai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Utility of formaldehyde cross-linking and mass spectrometry in the study of protein–protein interactions
- (2008) Brent W. Sutherland et al. JOURNAL OF MASS SPECTROMETRY
- Bcl-XL Inhibits Membrane Permeabilization by Competing with Bax
- (2008) Lieven P Billen et al. PLOS BIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started